Ryusuke Kizawa

Ryusuke Kizawa

Auto-generated profile, based on publicly available information

Ryusuke Kizawa

Department of Biochemistry The Jikei University School of Medicine Tokyo Japan

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2022 in Cancer Science
Verified
Journal Article
Open access
KYKohji Yamada
Kohji Yamada
RKRyusuke Kizawa
Ryusuke Kizawa
AYAyano Yoshida
Ayano Yoshida
RKRei Koizumi
Rei Koizumi
SMSaya Motohashi
Saya Motohashi
KYKiyotsugu Yoshida
Kiyotsugu Yoshida
Protein kinase C delta (PKCδ) is a multifunctional PKC family member and has been implicated in many types of cancers, including liver cancer. Recently, we have reported that PKCδ is secreted from liver cancer cells, and involved in cell proliferation and tumor growth. However, it remains unclear whether the extracellular PKCδ directly regulates cell surface growth factor receptors. Here, we identify epidermal growth factor receptor (EGFR) as a novel interacting protein of the cell surface PKCδ in liver cancer cells. Imaging studies showed that secreted PKCδ interacted with EGFR‐expressing cells in both autocrine and paracrine manners. Biochemical analysis revealed that PKCδ bound to the extracellular domain of EGFR. We further found that a part of the amino acid sequence on the C‐terminal region of PKCδ was similar to the putative EGFR binding site of EGF. In this regard, the point mutant of PKCδ in the binding site lacked the ability to bind to the extracellular domain of EGFR. Upon an extracellular PKCδ‐EGFR association, ERK1/2 activation, downstream of EGFR signaling, was apparently induced in liver cancer cells. This study indicates that extracellular PKCδ behaves as a growth factor and provides a molecular basis for extracellular PKCδ‐targeting therapy for liver cancer.

29 October 2026 in Respirology Case Reports
Verified
Journal Article
Open access
RKRyusuke Kizawa
Ryusuke Kizawa
ZSZenya Saito
Zenya Saito
KMKohei Minekawa
Kohei Minekawa
MTMakiko Takatsuka
Makiko Takatsuka
TKTakaaki Kitayama
Takaaki Kitayama
JAJun Araya
Jun Araya
Recurrent atelectasis is occasionally encountered in clinical practice but may be attributed to repeated respiratory infections without thorough investigation, potentially delaying the diagnosis of the underlying cause. We report a 78‐year‐old woman with well‐controlled asthma who developed recurrent right middle lobe and lingular atelectasis. Bronchoscopy revealed severe pinhole‐like narrowing of multiple central bronchi. Although allergic bronchopulmonary mycosis and post‐infectious cicatricial stenosis were initially considered, characteristic eosinophilic mucus impaction was absent, and endobronchial biopsy demonstrated marked eosinophilic inflammation of the bronchial wall with airway remodelling. Oral corticosteroid therapy resulted in resolution of the atelectasis and improvement of the bronchial narrowing. This case highlights eosinophilic bronchial inflammation as a rare but reversible cause of central bronchial narrowing and underscores the diagnostic value of endobronchial biopsy in patients with unexplained recurrent atelectasis.